Distinctions between Dopamine Transporter Antagonists Could be Just around the Bend
Authors:
- L. Keith HenryLHL. Keith Henry
- Randy D. BlakelyRBRandy D. Blakely
- 1 March 2008
- journal article
- editorial
- Published by Elsevier in Molecular Pharmacology
- Vol. 73 (3) , 616-618
Abstract
Abuse of psychostimulants such as cocaine and amphetamines has a tremendous social and economic impact. Although replacement therapies are offered for addiction to opioids, nicotine, and alcohol, there is no approved replacement treatment for psychostimulant addiction. Recent studies on an emerging group of benztropine- and rimcazole-based compounds provide hope that replacement therapies for cocaine and amphetamine addiction may come in the near future. A new study (p. 813) now investigates the molecular interaction of the benztropine and rimcazole compounds with their target, the dopamine transporter, and provides an intriguing explanation as to why use of these compounds, unlike cocaine, do not lead to locomotor stimulation and drug discrimination behaviors in animal models.Keywords
This publication has 14 references indexed in Scilit:
- Relationship between Conformational Changes in the Dopamine Transporter and Cocaine-Like Subjective Effects of Uptake InhibitorsMolecular Pharmacology, 2008
- Desvenlafaxine Succinate Identifies Novel Antagonist Binding Determinants in the Human Norepinephrine TransporterThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporterProceedings of the National Academy of Sciences, 2006
- Human Genetics and Pharmacology of Neurotransmitter Transporters2006
- The neuroscience of addictionNature Neuroscience, 2005
- Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transportersNature, 2005
- Uptake Inhibitors but not Substrates Induce Protease Resistance in Extracellular Loop Two of the Dopamine TransporterMolecular Pharmacology, 2004
- Identification of Intracellular Residues in the Dopamine Transporter Critical for Regulation of Transporter Conformation and Cocaine BindingJournal of Biological Chemistry, 2004
- Drug addictions: towards socially accepted and medically treatable diseasesNature Reviews Drug Discovery, 2002
- Generation of an activating Zn 2+ switch in the dopamine transporter: Mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycleProceedings of the National Academy of Sciences, 2002